Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
Oramed Pharmaceuticals will be added to the Russell 2000 and Russell 3000 indexes effective at the market open on June 29, following the semi-annual reconstitution. Membership is determined by objective market-capitalization rankings as of April 30, placing Oramed among the 4,000 largest U.S. stocks. The inclusion could lead to increased demand from index funds, as approximately $12.2 trillion in assets is benchmarked to Russell U.S.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.